​

LENZ Therapeutics Ownership | Who Owns LENZ Therapeutics?

OverviewForecastFinancialsChartTranscripts

LENZ Therapeutics Ownership Summary

LENZ Therapeutics is owned by 88.04% institutional investors, 2.73% insiders, and 9.23% retail investors. Ra capital management is the largest institutional shareholder, holding 14.88% of LENZ shares.

LENZ Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLENZ Therapeutics88.04%2.73%9.23%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management4.18M14.88%$122.48M
Alpha wave global, lp3.61M12.86%$105.87M
Blackrock funding, inc. /de1.43M5.10%$41.99M
Adage capital partners gp1.12M4.00%$32.91M
Sectoral asset management977.25K3.48%$28.64M
Tang capital management897.62K3.20%$26.31M
Rtw investments, lp863.39K3.07%$25.31M
Point72 asset management618.14K2.20%$18.12M
Ally bridge group (ny)343.32K1.22%$10.06M
Samsara biocapital343.01K1.22%$10.05M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sectoral asset management977.25K18.91%$28.64M
Alpha wave global, lp3.61M11.41%$105.87M
Ally bridge group (ny)343.32K8.37%$10.06M
Saturn v capital management342.31K4.07%$10.03M
Ra capital management4.18M2.06%$122.48M
Samsara biocapital343.01K2.06%$10.05M
Stempoint capital lp183.91K1.73%$5.39M
Tang capital management897.62K1.33%$26.31M
Scoggin management lp200.00K1.22%$5.86M
Knott david m jr82.00K1.09%$2.40M

Top Buyers

HolderShares% AssetsChange
Adage capital partners gp1.12M0.06%585.00K
Ally bridge group (ny)343.32K8.37%343.32K
Saturn v capital management342.31K4.07%342.31K
Blackrock funding, inc. /de1.43M0.00%265.94K
Summit partners public asset management240.00K0.18%240.00K

Top Sellers

HolderShares% AssetsChange
Point72 asset management618.14K0.04%-234.10K
Samsara biocapital343.01K2.06%-183.38K
Ikarian capital---149.50K
Manufacturers life insurance company, the---42.23K
Bbr partners---40.00K

New Positions

HolderShares% AssetsChangeValue
Ally bridge group (ny)343.32K8.37%343.32K$10.06M
Saturn v capital management342.31K4.07%342.31K$10.03M
Summit partners public asset management240.00K0.18%240.00K$7.03M
Stempoint capital lp183.91K1.73%183.91K$5.39M
Candriam s.c.a.171.27K0.03%171.27K$5.02M

Sold Out

HolderChange
Fortitude family office-9.00
Smartleaf asset management-11.00
Coldstream capital management-16.00
Assetmark-21.00
Quadrant capital group-27.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202511610.48%24,721,51417.75%881.51%7943.64%14-46.15%
Mar 31, 202510616.48%21,119,1009.06%761.51%575.56%2630.00%
Dec 31, 20249319.23%19,863,8136.02%731.54%5630.23%2025.00%
Sep 30, 20247823.81%18,735,645-0.94%681.26%43-4.44%16300.00%
Jun 30, 20246314.55%18,913,54216.53%731.84%45-18.18%4-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 25, 2025Versant Venture Capital VI, L.P.-Sell$1.99M
Aug 25, 2025Versant Venture Capital VI, L.P.-Sell$85.79K
Aug 22, 2025Versant Venture Capital VI, L.P.-Sell$820.33K
Aug 22, 2025Versant Venture Capital VI, L.P.-Sell$230.06K
Aug 26, 2025Versant Venture Capital VI, L.P.-Sell$1.71M

Insider Transactions Trends

DateBuySell
2025 Q3-17
2025 Q2-5
2025 Q1--
2024 Q4--
2024 Q3--

LENZ Ownership FAQ

Who Owns LENZ Therapeutics?

LENZ Therapeutics shareholders are primarily institutional investors at 88.04%, followed by 2.73% insiders and 9.23% retail investors. The average institutional ownership in LENZ Therapeutics's industry, Biotech Stocks , is 306.59%, which LENZ Therapeutics falls below.

Who owns the most shares of LENZ Therapeutics?

LENZ Therapeutics’s largest shareholders are Ra capital management (4.18M shares, 14.88%), Alpha wave global, lp (3.61M shares, 12.86%), and Blackrock funding, inc. /de (1.43M shares, 5.10%). Together, they hold 32.85% of LENZ Therapeutics’s total shares outstanding.

Does Blackrock own LENZ Therapeutics?

BlackRock is not among the top 10 institutional shareholders of LENZ Therapeutics.

Who is LENZ Therapeutics’s biggest shareholder by percentage of total assets invested?

Sectoral asset management is LENZ Therapeutics’s biggest shareholder by percentage of total assets invested, with 18.91% of its assets in 977.24K LENZ Therapeutics shares, valued at 28.64M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools